Atividade antiproliferativa do composto bioativo de Silybum marianum em linhagem celular de melanoma humano com mutação BRAF: potencial para reposicionamento terapêutico
Open Access
- 30 June 2025
- journal article
- Published by Fiocruz - Instituto de Tecnologia em Farmacos in Revista Fitos
- Vol. 19 (1) , e1812
Abstract
This study investigated the in vitro antiproliferative potential of Silibinin on human melanoma cells with a BRAF gene mutation. Cell viability was assessed through incubation with different concentrations (41, 104, 207, and 518 µM) for 48 hours, using the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), which involves the reduction of the tetrazolium salt. The inhibitory concentration (IC50) was determined to be 240 µM. Bright-field microscopy revealed loss of cell adhesion to the substrate, a characteristic feature of cell death by apoptosis, across the tested doses. These results highlight the need for further studies to elucidate the mechanism of action and confirm its clinical efficacy.Keywords
This publication has 12 references indexed in Scilit:
- Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma CellsCurrent Pharmaceutical Biotechnology, 2025
- The treatment of advanced melanoma: Current approaches and new challengesCritical Reviews in Oncology/Hematology, 2024
- Silybum marianum: An Overview of its Phytochemistry and Pharmacological Activities with Emphasis on Potential Anticancer PropertiesAnti-Cancer Agents in Medicinal Chemistry, 2023
- The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidenceJournal of Ethnopharmacology, 2021
- Drug repurposing for cancer therapy, easier said than doneSeminars in Cancer Biology, 2021
- Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and ApplicationsJournal of Agricultural and Food Chemistry, 2020
- Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesPhytotherapy Research, 2018
- Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant MelanomaJournal of Pharmacy & Pharmaceutical Sciences, 2018
- Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell GrowthCancer Prevention Research, 2013
- Silibinin – A Promising New Treatment for CancerAnti-Cancer Agents in Medicinal Chemistry, 2010